![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Lorenzini, Theo 
ORCID: https://orcid.org/0000-0003-3377-032X; Cadilha, Bruno L. ORCID: https://orcid.org/0000-0001-7045-3898; Obeck, Hannah; Benmebarek, Mohamed-Reda; Märkl, Florian ORCID: https://orcid.org/0000-0003-4285-0380; Michaelides, Stefanos; Strzalkowski, Thaddäus; Briukhovetska, Daria; Müller, Philipp Jie; Nandi, Sayantan; Winter, Pia; Majed, Lina; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Seifert, Matthias ORCID: https://orcid.org/0000-0002-6581-6196; Rausch, Svenja; Feuchtinger, Tobias ORCID: https://orcid.org/0000-0002-8517-9681; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2023):
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
In: British Journal of Cancer, Bd. 129, Nr. 4: S. 696-705
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-3377-032X; Cadilha, Bruno L. ORCID: https://orcid.org/0000-0001-7045-3898; Obeck, Hannah; Benmebarek, Mohamed-Reda; Märkl, Florian ORCID: https://orcid.org/0000-0003-4285-0380; Michaelides, Stefanos; Strzalkowski, Thaddäus; Briukhovetska, Daria; Müller, Philipp Jie; Nandi, Sayantan; Winter, Pia; Majed, Lina; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Seifert, Matthias ORCID: https://orcid.org/0000-0002-6581-6196; Rausch, Svenja; Feuchtinger, Tobias ORCID: https://orcid.org/0000-0002-8517-9681; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2023):
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
In: British Journal of Cancer, Bd. 129, Nr. 4: S. 696-705
[PDF, 2MB]
Seifert, Matthias; Benmebarek, Mohamed-Reda; Briukhovetska, Daria; Märkl, Florian; Dörr, Janina; Cadilha, Bruno L.; Jobst, Jakob; Stock, Sophia ORCID: https://orcid.org/0000-0002-5072-5013; Andreu-Sanz, David; Lorenzini, Theo; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Oner, Arman; Obeck, Hannah; Majed, Lina; Dhoqina, Dario; Feinendegen, Manouk; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Zhang, Jin; Schindler, Ulrike; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function.
In: British Journal of Cancer, Bd. 127, Nr. 12: S. 2175-2185
[PDF, 845kB]
ORCID: https://orcid.org/0000-0002-5072-5013; Andreu-Sanz, David; Lorenzini, Theo; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Oner, Arman; Obeck, Hannah; Majed, Lina; Dhoqina, Dario; Feinendegen, Manouk; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Zhang, Jin; Schindler, Ulrike; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function.
In: British Journal of Cancer, Bd. 127, Nr. 12: S. 2175-2185
[PDF, 845kB]